Fingerprint
Dive into the research topics of 'Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapy
Aaron D. Schenone, Jingqin Luo, Luke Montgomery, Daniel Morgensztern, Douglas R. Adkins, Brian A. Van Tine
- Division of Public Health Sciences
- Siteman Cancer Center
- Institute of Clinical and Translational Sciences (ICTS)
- Section of Medical Oncology
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Institute for Public Health
- DBBS - Molecular Cell Biology
- DBBS - Molecular Genetics and Genomics
- DBBS - Cancer Biology
- Brain Tumor Center
Research output: Contribution to journal › Article › peer-review
11
Scopus
citations